By leveraging the vast amount of knowledge available in biology and medicine with computational models of diseases, we are committed to improving clinical trials efficiency.
Patients are a scarce and precious resource. Each trial tests just one hypothesis. jinkō offers the ability to test, compare, and optimize trial protocol designs on thousands of digital patients before accruing human subjects. This process informs and de-risks decision-making each step of the way. jinkō helps drug developers bring innovative medicines to market faster. It is also cheaper, and with greater efficiency.
We foster a culture of transparent communication to build trust and accountability. NOVA’s cultural attributes are: integrity, emergent leadership, comfort with ambiguity and intellectual humility.
